Join us if you want to:
- Explore advances in AF treatment, left atrial appendage management, and surgical coronary revascularization.
- Gain insights from expert faculty, contemporary surgical techniques, and case-based discussions.
- Learn how innovative technologies support minimally invasive cardiothoracic procedures.
- Enhance multidisciplinary,patient centered care through evolving clinical evidence and best practice
Agenda
Date: Friday 9 October 2026
Time: 12:15–13:30 CEST
Room: 114 on L1
| Time CEST | Topic | Faculty |
| 12:15–12:20 | Welcome & Introductions |
Prof. Jean-Christian Roussel & Dr. Manuel Castella |
| 12:20–12:35 | Long-term outcomes of single-and dual-staged hybrid AF ablation | Dr. Luca Aerts |
| 12:35–12:50 | Hybrid treatment of persistent and long-standing persistent AF (Hy5 approach) | Dr. Mahmoud Wehbe |
| 12:50–13:05 | EndoCAB single- and multivessel coronary revascularization with concomitant surgical AF ablation and LAA exclusion | Dr. Ferdi Akca |
| 13:05–13:15 | Concomitant surgical AF treatment in minimally invasive aortic valve surgery | Dr. Jelle Fleerakkers |
| 13:15–13:30 | Penditure™: advancing simplicity and precision in LAA closure | Prof. Thorsten Hanke |
| 13:30–13:35 | Conclusion and final remarks | Dr. Manuel Castella & Prof. Jean-Christian Roussel |